TRB Chemedica Hong Kong was established in 1981 and is the first subsidiary of TRB CHEMEDICA, a Swiss pharmaceutical group providing solutions in more than 70 countries around the world.
Our group is mainly focused on therapeutic areas such as ophthalmology, rheumatology and neurology. Clinical research and privileged exchanges with both healthcare professionals and patients are always at the heart of our product development. TRB’s particular expertise lies above all in the production, packaging and therapeutic options relating to hyaluronic acid. These skills are evident throughout our wide range of products and related patents. Our Swiss affiliate, TRB CHEMEDICA SA, is based in Vouvry, in Valais. On this site, two manufacturing units and a research & development department work closely together. It’s also where the whole range of OSTENIL® products are manufactured.
TRB CHEMEDICA Hong Kong’s portfolio includes ophthalmological products as VISMED® – hyaluronic acid based eye drops.In orthopaedics,OSTENIL® product range – intraarticular injections to treat osteoarthritis, VISCOSEAL® – post-arthroscopy synovial fluid replacement and ARTRODAR® – the first interleukin-1 inhibitor in osteoarthritis.
Celebrating 40 years of serving the community in Hong Kong, we shall containue to dedicate our efforts to bring top quality products to patients and enhance their well-being and quality of life.